Myriad Genetics Inc - Company Profile

Powered by

All the data and insights you need on Myriad Genetics Inc in one report.

$395 $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date Myriad Genetics Inc Strategy Report

  • Understand Myriad Genetics Inc position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Myriad Genetics Inc: Overview

Select Item

Myriad Genetics Inc (Myriad) is a specialty molecular diagnostic company, engaged in the discovery and commercialization of molecular diagnostic tests, and personalized medicine, and provides pharmaceutical and clinical services for major diseases. The company’s product portfolio includes molecular diagnostic testing products that analyze genes, genetic expressions, and corresponding proteins to assess a person’s risk for developing diseases later in life; products related to diagnosis of disease; and determine a patient’s likelihood of responding to a particular drug. Myriad markets its products through sales force in Europe and Canada and distributor agreements in countries in Canada, Middle East, Asia, and Australia. The company has operations in the US, Spain, France, Switzerland, the UK, Canada, Italy, Germany, Japan, Australia, and the Netherlands. Myriad is headquartered in Salt Lake City, Utah, the US.

 Gain a 360-degree view of Myriad Genetics Inc and make more informed decisions for your business Gain a 360-degree view of Myriad Genetics Inc and make more informed decisions for your business Find out more
Headquarters United States of America
Address 322 North 2200 West, Salt Lake City, Utah, 84116
Website myriad.com
Telephone 1 801 5843600
No of Employees 2,700
Industry Medical Equipment
Ticker Symbol & Exchange MYGN (NASD)
Revenue (2023) $753.2M
EPS XYZ
Market Cap* $1.8B
Net Profit Margin (2023) XYZ -111.8%
   
* As of and is in US$
View Myriad Genetics Inc financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Myriad Genetics Inc premium industry data and analytics

120+

Medical Clinical Trials

A database of clinical trials planned, currently ongoing, completed, suspended, withdrawn, and terminated in countries around the world.

30+

Medical Pipeline Products

A database of medical devices that are in the process to get approved for sale around the world. Devices that are in development, through to those in the approval process are included.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Myriad Genetics Inc’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Brands
- -
BRAC Analysis BRACAnalysis
Colaris BRACAnalysis CDx
XYZ XYZ
XYZ XYZ
XYZ XYZ
Understand Myriad Genetics Inc portfolio and identify potential areas for collaboration Understand Myriad Genetics Inc portfolio and identify potential areas for collaboration Find out more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2024 Asset Purchase In February, the company acquired select assets including the Precise Tumor Test, the Precise Liquid Test, and IPG’s CLIA-certified laboratory in St. George, Utah, the US from Intermountain Precision Genomics.
2024 Contracts/Agreements In February, the company partnered with the National Cancer Center Hospital East in Japan to investigate the prognostic and predictive significance of molecular residual disease testing.
2024 Contracts/Agreements In January, the company signed an agreement to acquire certain assets from Intermountain Precision Genomics’ laboratory business.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Find out more
Image for loader

Competitor Comparison

Key Parameters Myriad Genetics Inc Quest Diagnostics Inc Hologic Inc Exact Sciences Corp Natera Inc
Headquarters United States of America United States of America United States of America United States of America United States of America
City Salt Lake City Secaucus Marlborough Madison Austin
State/Province Utah New Jersey Massachusetts Wisconsin Texas
No. of Employees 2,700 40,000 6,990 6,500 3,282
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
S. Louise Phanstiel Chairman Executive Board - 64
Paul J. Diaz Chief Executive Officer; President; Director Executive Board 2020 61
Scott Leffler Chief Financial Officer Senior Management 2024 -
Sam Raha Chief Operating Officer Senior Management 2023 -
Kevin R. Haas, Ph.D. Chief Technology Officer Senior Management - 38
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Myriad Genetics Inc key executives to enhance your sales strategy Gain insight into Myriad Genetics Inc key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward